A detailed history of Allspring Global Investments Holdings, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 9,745 shares of CTLT stock, worth $575,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,745
Previous 8,687 12.18%
Holding current value
$575,929
Previous $488,000 20.9%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$56.16 - $60.96 $59,417 - $64,495
1,058 Added 12.18%
9,745 $590,000
Q2 2024

Jul 26, 2024

SELL
$53.58 - $57.02 $15,859 - $16,877
-296 Reduced 3.3%
8,687 $488,000
Q1 2024

Apr 18, 2024

BUY
$42.56 - $59.82 $2,681 - $3,768
63 Added 0.71%
8,983 $507,000
Q4 2023

Jan 25, 2024

SELL
$32.18 - $46.57 $13,386 - $19,373
-416 Reduced 4.46%
8,920 $400,000
Q3 2023

Oct 27, 2023

BUY
$44.2 - $50.2 $412,651 - $468,667
9,336 New
9,336 $425,000
Q2 2023

Jul 18, 2023

SELL
$31.86 - $67.26 $2.33 Million - $4.93 Million
-73,258 Reduced 78.7%
19,828 $859,000
Q1 2023

Apr 13, 2023

SELL
$45.44 - $74.26 $962,510 - $1.57 Million
-21,182 Reduced 18.54%
93,086 $6.12 Million
Q4 2022

Jan 23, 2023

SELL
$41.39 - $81.0 $35 Million - $68.4 Million
-844,477 Reduced 88.08%
114,268 $0
Q3 2022

Oct 26, 2022

SELL
$72.36 - $113.1 $85,746 - $134,023
-1,185 Reduced 0.12%
958,745 $69.4 Million
Q2 2022

Jul 25, 2022

BUY
$87.2 - $114.05 $23.8 Million - $31.2 Million
273,501 Added 39.84%
959,930 $103 Million
Q1 2022

May 02, 2022

BUY
$94.19 - $124.49 $62.1 Million - $82 Million
658,956 Added 2398.56%
686,429 $76.1 Million
Q4 2021

Jan 28, 2022

BUY
$119.57 - $139.07 $3.28 Million - $3.82 Million
27,473 New
27,473 $3.52 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.